Association of Parkinson's disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study

被引:56
作者
Fink, H. A. [1 ,2 ,3 ,4 ]
Kuskowski, M. A. [1 ]
Taylor, B. C. [2 ,4 ]
Schousboe, J. T. [5 ,6 ]
Orwoll, E. S. [7 ]
Ensrud, K. E. [2 ,3 ,4 ]
机构
[1] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA
[2] Vet Adm Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA
[6] Pk Nicollet Hlth Serv, Div Rheumatol, Minneapolis, MN USA
[7] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA
关键词
bone density; fractures; mortality; osteoporosis; Parkinson's disease;
D O I
10.1007/s00198-008-0584-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among community-dwelling older men, compared to those without Parkinson's disease (PD), over approximately 5 years, those with baseline PD had a significantly greater rate of annualized total hip bone loss (-1.1% vs. 0.4%), proportion of incident non-spine fractures (14.9% vs. 7.2%) and mortality (34.8% vs. 9.5%). Introduction The objective of this study was to examine the association of Parkinson's disease (PD) with bone loss and fractures in older men. Methods This prospective cohort study analyzed data from 5,937 community dwelling men aged >= 65 years at six clinical centers of the Osteoporotic Fractures in Men (MrOS) Study. At baseline and visit two (mean interval 4.6 +/- 0.4 SD years), community-diagnosed PD was ascertained by self-report and hip bone mineral density (BMD) was measured using dual energy x-ray absorptiometry (DXA). Incident fractures were self-reported. Fractures and deaths were centrally adjudicated. Results At baseline, 46 (0.8%) men had PD. Age-adjusted mean annualized total hip bone loss was greater in men with vs. those without PD (-1.08% vs. -0.36%, p < 0.001). 15.2% of men with PD and 7.2% of men without PD experienced an incident non-spine fracture (age-adjusted HR 2.4, 95%CI 1.1-5.0). 34.8% of men with PD and 9.5% of men without PD died during follow-up (age-adjusted HR 3.5, 95%CI 2.2-5.5). Associations of PD with bone loss, fractures and mortality were modestly altered by additional individual adjustment for possible confounders. Conclusions In community-dwelling older men, PD was associated with increased bone loss, fractures and mortality. In addition to implementing fall prevention measures, clinicians should consider osteoporosis screening in older men with PD.
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 23 条
[11]   RISK-FACTORS FOR RECURRENT NONSYNCOPAL FALLS - A PROSPECTIVE-STUDY [J].
NEVITT, MC ;
CUMMINGS, SR ;
KIDD, S ;
BLACK, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (18) :2663-2668
[12]   Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study - A large observational study of the determinants of fracture in older men [J].
Orwoll, E ;
Blank, JB ;
Barrett-Connor, E ;
Cauley, J ;
Cummings, S ;
Ensrud, K ;
Lewis, C ;
Cawthon, PM ;
Marcus, R ;
Marshall, LM ;
McGowan, J ;
Phipps, K ;
Sherman, S ;
Stefanick, ML ;
Stone, K .
CONTEMPORARY CLINICAL TRIALS, 2005, 26 (05) :569-585
[13]   RETRACTED: Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency (Retracted article. See vol. 106, pg. 212, 2018) [J].
Sato, Y ;
Honda, Y ;
Kaji, M ;
Asoh, T ;
Hosokawa, K ;
Kondo, I ;
Satoh, K .
BONE, 2002, 31 (01) :114-118
[14]   RETRACTED: Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson's disease (Retracted article. See vol. 89, 2018) [J].
Sato, Y ;
Manabe, S ;
Kuno, H ;
Oizumi, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (01) :64-68
[15]   RETRACTED: High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease (Retracted article. See vol. 94, pg. 804, 2020) [J].
Sato, Y ;
Kikuyama, M ;
Oizumi, K .
NEUROLOGY, 1997, 49 (05) :1273-1278
[16]   RETRACTED: Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease(Retracted article.See vol.87,pg.239,2016) [J].
Sato, Yoshihiro ;
Honda, Yoshiaki ;
Iwamoto, Jun .
NEUROLOGY, 2007, 68 (12) :911-915
[17]   RETRACTED: Alendronate and Vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial (Retracted Article) [J].
Sato, Yoshihiro ;
Iwamoto, Jun ;
Kanoko, Tomohiro ;
Satoh, Kei .
MOVEMENT DISORDERS, 2006, 21 (07) :924-929
[18]   Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study [J].
Szulc, P. ;
Delmas, P. D. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (04) :495-503
[19]   REDUCED BONE-DENSITY OF THE HIP IN ELDERLY PATIENTS WITH PARKINSONS-DISEASE [J].
TAGGART, H ;
CRAWFORD, V .
AGE AND AGEING, 1995, 24 (04) :326-328
[20]   Long-term prediction of incident hip fracture risk in elderly white women: Study of osteoporotic fractures [J].
Taylor, BC ;
Schreiner, PJ ;
Stone, KL ;
Fink, HA ;
Cummings, SR ;
Nevitt, MC ;
Bowman, PJ ;
Ensrud, KE .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (09) :1479-1486